EUVIMEDTutustu EUVIMEDiin
Open access · CC BY-NC-ND 4.0

Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells

Mehdi Dehghani iD, Meng Chai, Nazanin Talebloo, Molly Morrissey, Andrew Larey, Paul Keselman, Anshul Rana, Mohammad Islam, Martha Mayo, Jordan Speidel, Prabuddha Mukherjee, Zheng Zhao and 18 more

ACS Nano · 2026-06-02 · 20 (21) · 15032-15060

DOI: 10.1021/acsnano.5c19046 ↗

At a glance

Journal article in ACS Nano, published online on 2026-05-18. Written by Mehdi Dehghani and 29 co-authors. Institution: Sartorius Stedim North America, Corporate Research Department, Marlborough, Massachusetts 01752, United States. Major MEDLINE topics: Mesenchymal Stem Cells, Extracellular Vesicles. Cited 2 times so far (Crossref); 131 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

The development of extracellular-vesicle-based therapeutics requires robust analytical assays and scalable downstream processing strategies to ensure product quality and reproducibility. In this study, we established an analytical toolbox comprising scattering and fluorescence mode nanoparticle tracking analysis, fluorescence-based flow cytometry, and multidetector analytical size-exclusion chromatography. Liposomes, selected for their biophysical similarity to EVs, were used as reference materials to optimize assay parameters, fluorescence labeling conditions, and dynamic range, minimizing artifacts such as photobleaching and masking effects. Using these optimized analytical tools, we established a scalable downstream processing (DSP) workflow for human bone marrow mesenchymal stromal cell-derived EVs (MSC-EVs), incorporating clarification, tangential flow filtration, ion exchange chromatography, buffer exchange, and sterile filtration. We first designed and optimized the DSP process at small scale using ion exchange chromatography (IEX). We integrated controls such as medium-alone control to ensure the cell-secreted nature of the final preparation. Using a stepwise elution strategy, IEX chromatography resulted in the elution of two cell-secreted populations. We then investigated the identities of these two IEX eluates using orthogonal analytical techniques. Transmission electron microscopy revealed that eluate 2 was enriched in EVs with a cup-shaped morphology, while eluate 1 contained nonvesicular extracellular particles (NVEPs). Eluate 2 also showed higher expression of positive markers such as CD81 and CD73 using Simple Western and expressed MSC-specific RNA markers compared with eluate 1. Proteomic and lipidomic analyses further validated the enrichment of EVs in eluate 2. Then, the analytical toolbox was utilized to monitor the DSP process for particle recovery and impurity removal throughout the process. Together, these results demonstrate that orthogonal analytics coupled to a scalable DSP yield reproducible MSC-EV preparations while depleting commonly co-isolated NVEPs. This practical framework advances process analytics of MSC-EV manufacturing and supports reporting of identity, purity, and function, aligned with existing guidelines in the field.

Subjects

MeSH terms (MEDLINE)

Mesenchymal Stem CellsExtracellular VesiclesHumansChromatography, Ion ExchangeFlow CytometryChromatography, Gel

Author keywords

analytical optimizationbioprocess analyticsbioprocessing designextracellular vesicles (EVs)mesenchymal stromal cells (MSCs)reproducibility and scalability

Authors and institutions

  • Sartorius Stedim North America, Corporate Research Department, Marlborough, Massachusetts 01752, United States.
  • Sartorius Stedim North America, Bioprocess Solutions Department, Marlborough, Massachusetts 01752, United States.
  • Rochester Institute of Technology, Biomedical Engineering Department, Rochester, New York 14623, United States.

ORCID profiles: Mehdi Dehghani, Thomas Gaborski

Cite

APA

Dehghani, M., Chai, M., Talebloo, N., Morrissey, M., Larey, A., Keselman, P., Rana, A., Islam, M., Mayo, M., Speidel, J., Mukherjee, P., Zhao, Z., Haridas, N., Marks, P., Chon, J., Kishimori, E., Gaborski, T., Kim, Y., Joshi, D., …, & Olszowy, M. (2026). Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells. ACS Nano, 20(21), 15032-15060. https://doi.org/10.1021/acsnano.5c19046

Vancouver

Dehghani M, Chai M, Talebloo N, Morrissey M, Larey A, Keselman P, et al. Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells. ACS Nano. 2026;20(21):15032-15060. doi:10.1021/acsnano.5c19046

BibTeX
@article{Dehghani2026,
  author = {Dehghani, Mehdi and Chai, Meng and Talebloo, Nazanin and Morrissey, Molly and Larey, Andrew and Keselman, Paul and Rana, Anshul and Islam, Mohammad and Mayo, Martha and Speidel, Jordan and Mukherjee, Prabuddha and Zhao, Zheng and Haridas, Namitha and Marks, Paul and Chon, John and Kishimori, Ethan and Gaborski, Thomas and Kim, Yuriy and Joshi, Deepika and Wu, Yuxuan and Lu, Yisheng and Cheng, Ran and Norton, Ryan and Zhong, Yichen and Lahooti, Behnaz and Trinidad, Camille and Black, Eric and Splan, David and Pollard, David and Olszowy, Michael},
  title = {Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells},
  journal = {ACS Nano},
  year = {2026},
  volume = {20},
  number = {21},
  pages = {15032--15060},
  doi = {10.1021/acsnano.5c19046}
}
Start for free →